Free Trial

Ultragenyx Pharmaceutical (RARE) Insider Trading & Ownership

Ultragenyx Pharmaceutical logo
$50.99
-0.85 (-1.64%)
(As of 10/31/2024 ET)

Ultragenyx Pharmaceutical (NASDAQ:RARE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$4.70 M
Get RARE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ultragenyx Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RARE Insider Buying and Selling by Quarter

Ultragenyx Pharmaceutical Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/10/2024Howard HornCFOSell7,465$52.76$393,853.40  
9/3/2024Emil D KakkisCEOSell20,000$55.85$1,117,000.00  
9/3/2024Theodore Alan HuizengaCAOSell91$56.19$5,113.29  
8/6/2024Emil D KakkisCEOSell20,000$50.17$1,003,400.00  
7/2/2024Corazon (Corsee) D SandersDirectorSell584$40.98$23,932.32  
6/12/2024Karah Herdman ParschauerEVPSell9,806$45.00$441,270.00  
6/10/2024Corazon (Corsee) D SandersDirectorSell1,737$41.10$71,390.70  
4/18/2024Eric CrombezEVPSell142$44.10$6,262.20  
3/11/2024Thomas Richard KassbergEVPSell11,509$49.93$574,644.37  
3/7/2024Matthew K FustDirectorSell12,195$50.88$620,481.60  
3/1/2024John Richard PinionInsiderSell4,173$53.76$224,340.48  
3/1/2024Karah Herdman ParschauerEVPSell3,756$53.76$201,922.56  
3/1/2024Theodore Alan HuizengaCAOSell341$53.76$18,332.16  
(Data available from 1/1/2013 forward)

RARE Insider Trading Activity - Frequently Asked Questions

5.80% of Ultragenyx Pharmaceutical stock is owned by insiders. Learn more on RARE's insider holdings.

The following insiders have sold RARE shares in the last 24 months: Camille L Bedrosian ($175,615.25), Corazon (Corsee) D Sanders ($199,377.87), Dennis Karl Huang ($17,757.85), Emil D Kakkis ($3,724,432.56), Eric Crombez ($6,262.20), Erik Harris ($242,461.00), Howard Horn ($393,853.40), John Richard Pinion ($324,940.48), Karah Herdman Parschauer ($840,202.56), Matthew K Fust ($620,481.60), Theodore Alan Huizenga ($264,746.71), and Thomas Richard Kassberg ($1,881,845.21).

Insiders have sold a total of 204,368 Ultragenyx Pharmaceutical shares in the last 24 months for a total of $8,691,976.69 sold.



This page (NASDAQ:RARE) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners